Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Ovarian Neoplasms

  Free Subscription


2 BMC Cancer
1 Eur J Obstet Gynecol Reprod Biol
3 Gynecol Oncol
1 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Cancer

  1. DENG J, Bai X, Feng X, Ni J, et al
    Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    BMC Cancer. 2019;19:618.
    PubMed     Text format     Abstract available

  2. ABU-SHAWER O, Abu-Shawer M, Hirmas N, Alhouri A, et al
    Hematologic markers of distant metastases and poor prognosis in gynecological cancers.
    BMC Cancer. 2019;19:141.
    PubMed     Text format     Abstract available

    Eur J Obstet Gynecol Reprod Biol

  3. ZHU X, Yang H, Lang J, Zhang Y, et al
    Ras association domain family protein 1a hypermethylation and PD-L1 expression in ovarian cancer: A retrospective study of 112 cases.
    Eur J Obstet Gynecol Reprod Biol. 2019;240:103-108.
    PubMed     Text format     Abstract available

    Gynecol Oncol

  4. KRANAWETTER M, Ataseven B, Grimm C, Schneider S, et al
    Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery.
    Gynecol Oncol. 2019 Jun 21. pii: S0090-8258(19)31331.
    PubMed     Text format     Abstract available

  5. CANAZ E, Grabowski JP, Richter R, Braicu EI, et al
    Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base.
    Gynecol Oncol. 2019 Jun 20. pii: S0090-8258(19)31327.
    PubMed     Text format     Abstract available

  6. FUH KC, Java JJ, Chan JK, Kapp DS, et al
    Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.
    Gynecol Oncol. 2019 Jun 19. pii: S0090-8258(19)31257.
    PubMed     Text format     Abstract available

    Oncol Rep

  7. CHEN D, Cao L, Wang X
    MPZL1 promotes tumor cell proliferation and migration via activation of Src kinase in ovarian cancer.
    Oncol Rep. 2019 Jun 12. doi: 10.3892/or.2019.7199.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.